A Pre-surgical Study of LDE225 in Men With High-risk Localized Prostate Cancer

NCT02111187 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: LDE225

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins